SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 87.20 |
| Enterprise Value ($M) | 72.90 |
| Book Value ($M) | -5.29 |
| Book Value / Share | -0.06 |
| Price / Book | -16.49 |
| NCAV ($M) | -6.83 |
| NCAV / Share | -0.07 |
| Price / NCAV | -12.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.93 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.74 |
| Current Ratio | 0.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 18.98 |
| Assets | 20.52 |
| Liabilities | 25.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -98.05 |
| Net Income | -100.51 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -84.77 |
| Cash from Investing | -0.26 |
| Cash from Financing | 74.54 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 1.10 | -81.65 | |
| 13G/A | Avidity Partners Management LP | 6.60 | -33.04 | |
| 13G/A | Janus Henderson Group Plc | 3.00 | -47.27 | |
| 13G/A | Adage Capital Management, L.P. | 1.55 | -75.00 | |
| 13G/A | Vanguard Group Inc | 4.35 | -16.52 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 149,380 | 427,692 | 34.93 | |
| 68,711 | 180,801 | 38.00 | |
| 329,241 | 784,918 | 41.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IDYA – IDEAYA Biosciences, Inc. | IFRX – InflaRx N.V. |
| IGMS – IGM Biosciences, Inc. | IMVT – Immunovant, Inc. |
| INBX – Inhibrx Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io